Literature DB >> 19461914

Time to Redefine the Role of Routine Combined-Modality Therapy for Invasive Stage-II/III Rectal Cancer?

Lily L Lai1, Charles R Thomas.   

Abstract

Year:  2009        PMID： 19461914      PMCID： PMC2684716     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  9 in total

1.  Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

Authors:  Carlo Capirci; Vincenzo Valentini; Luca Cionini; Antonino De Paoli; Claus Rodel; Robert Glynne-Jones; Claudio Coco; Mario Romano; Giovanna Mantello; Silvia Palazzi; Falchetti Osti Mattia; Maria Luisa Friso; Domenico Genovesi; Cristiana Vidali; Maria Antonietta Gambacorta; Alberto Buffoli; Marco Lupattelli; Maria Silvia Favretto; Giuseppe La Torre
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-11       Impact factor: 7.038

2.  Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study.

Authors: 
Journal:  BMJ       Date:  2006-09-19

3.  Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial.

Authors:  Ka Lau Leung; Samuel P Y Kwok; Steve C W Lam; Janet F Y Lee; Raymond Y C Yiu; Simon S M Ng; Paul B S Lai; Wan Yee Lau
Journal:  Lancet       Date:  2004-04-10       Impact factor: 79.321

4.  Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.

Authors:  Hak-Mien Quah; Joanne F Chou; Mithat Gonen; Jinru Shia; Deborah Schrag; Leonard B Saltz; Karyn A Goodman; Bruce D Minsky; W Douglas Wong; Martin R Weiser
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

5.  Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.

Authors:  Federica Bertolini; Carmelo Bengala; Luisa Losi; Maria Pagano; Francesco Iachetta; Cristina Dealis; Gordana Jovic; Roberta Depenni; Sandra Zironi; Anna Maria Falchi; Gabriele Luppi; Pier Franco Conte
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-18       Impact factor: 7.038

6.  Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

Authors:  Yih-Huei Uen; Shiu-Ru Lin; Deng-Chyang Wu; Yu-Chung Su; Jeng-Yih Wu; Tian-Lu Cheng; Chin-Wen Chi; Jaw-Yuan Wang
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

7.  Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group.

Authors:  David G Jayne; Pierre J Guillou; Helen Thorpe; Philip Quirke; Joanne Copeland; Adrian M H Smith; Richard M Heath; Julia M Brown
Journal:  J Clin Oncol       Date:  2007-07-20       Impact factor: 44.544

Review 8.  American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.

Authors:  Carmen J Allegra; J Milburn Jessup; Mark R Somerfield; Stanley R Hamilton; Elizabeth H Hammond; Daniel F Hayes; Pamela K McAllister; Roscoe F Morton; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

9.  Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy.

Authors:  F V Negri; N Campanini; R Camisa; F Pucci; S Bui; G Ceccon; R Martinelli; M Fumagalli; P L Losardo; P Crafa; C Bordi; S Cascinu; A Ardizzoni
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.